Date published: 2026-3-9

1-800-457-3801

SCBT Portrait Logo
Seach Input

MOSPD3 Inhibitors

MOSPD3 inhibitors comprise a category of chemical agents specifically designed to target and impede the function of the protein MOSPD3, which plays a role in various cellular processes. These inhibitors function by binding to the MOSPD3 protein or by interacting with the signaling pathways and molecular interactions that involve MOSPD3, consequently leading to a reduction in its activity within the cell. The inhibition mechanism can occur through direct interaction with the protein's active sites or allosteric sites, which can cause conformational changes that reduce MOSPD3's ability to participate in its normal cellular functions. Some inhibitors work by disrupting the protein's interaction with other molecules, effectively isolating it and preventing it from carrying out its role in intracellular signaling or transport. Others might interfere with the post-translational modifications of MOSPD3, which are crucial for its proper localization and function. By inhibiting these modifications, the inhibitors can preclude the protein from reaching its intended cellular destination or from adopting the necessary configuration to interact with other proteins or cellular structures. The development of MOSPD3 inhibitors is grounded in the understanding of the protein's role in cell biology and its involvement in specific cellular pathways. Since MOSPD3 is implicated in the modulation of cellular transport mechanisms, inhibitors that target this protein can lead to alterations in the dynamics of vesicle trafficking and membrane fusion events within the cell. This can influence a variety of cellular processes, from the regulation of membrane protein expression to the secretion of signaling molecules. The inhibitors might also impact the protein's interaction with cytoskeletal elements, which is crucial for maintaining cellular structure and facilitating intracellular transport. By disrupting these interactions, MOSPD3 inhibitors can cause a rearrangement of the cellular architecture, influencing the protein's ability to contribute to the maintenance of cellular integrity and the execution of its transport-related functions. These chemical compounds are specifically engineered to ensure precision in targeting MOSPD3, aiming to achieve maximal inhibition with minimal off-target effects, thus providing a tool to dissect the protein's role and manipulate its activity within the cell.

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 is a specific inhibitor of phosphoinositide 3-kinases (PI3K), which play a key role in various signaling pathways, including those regulating membrane trafficking. MOSPD3, a membrane-associated protein, may rely on PI3K-dependent trafficking to function properly. Thus, LY294002 can indirectly reduce MOSPD3 activity by hindering its transport to the membrane.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin is an mTOR inhibitor that can indirectly affect MOSPD3 by downregulating cellular processes such as protein synthesis and trafficking, which are crucial for the maintenance of membrane proteins. By inhibiting mTOR, Rapamycin may decrease the overall expression and membrane localization of MOSPD3.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Wortmannin is another potent and irreversible inhibitor of PI3K. Similar to LY294002, Wortmannin can disrupt the PI3K pathway, which is essential for membrane dynamics and protein trafficking. This disruption can indirectly lead to reduced MOSPD3 activity by affecting its membrane association.

Dynamin Inhibitor I, Dynasore

304448-55-3sc-202592
10 mg
$89.00
44
(2)

Dynasore is a GTPase inhibitor that targets dynamin, a protein involved in endocytosis and vesicle trafficking. By inhibiting dynamin, Dynasore can affect the endocytic recycling of membrane proteins like MOSPD3, leading to decreased functional activity at the cell surface.

Brefeldin A

20350-15-6sc-200861C
sc-200861
sc-200861A
sc-200861B
1 mg
5 mg
25 mg
100 mg
$31.00
$53.00
$124.00
$374.00
25
(3)

Brefeldin A is an inhibitor of ADP-ribosylation factor (ARF), a small GTPase involved in the formation of the coat protein complex I (COPI) vesicle. By disrupting vesicular transport, Brefeldin A can indirectly inhibit the trafficking of MOSPD3 to the membrane.

Cytochalasin D

22144-77-0sc-201442
sc-201442A
1 mg
5 mg
$165.00
$486.00
64
(4)

Cytochalasin D disrupts the actin cytoskeleton, which is crucial for various cellular processes, including vesicle movement and membrane dynamics. By destabilizing actin filaments, Cytochalasin D can indirectly inhibit MOSPD3's association with the membrane.

Gö 6976

136194-77-9sc-221684
500 µg
$227.00
8
(1)

Gö6976 is a potent inhibitor of certain protein kinase C (PKC) isoenzymes. PKC is involved in signaling pathways that regulate cellular adhesion and movement, which could affect the localization and function of MOSPD3. By inhibiting PKC, Gö6976 may reduce the surface expression of MOSPD3.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

PD98059 is a selective inhibitor of mitogen-activated protein kinase kinase (MEK), which is part of the MAPK/ERK pathway. The MAPK/ERK pathway is involved in cell proliferation and differentiation, which can influence the expression and functionality of MOSPD3. By inhibiting MEK, PD98059 may indirectly decrease MOSPD3 activity.

NF449

627034-85-9sc-478179
sc-478179A
sc-478179B
10 mg
25 mg
100 mg
$203.00
$469.00
$1509.00
1
(0)

NF449 is a potent and selective antagonist of G-protein coupled receptor P2X1, which is involved in ATP-mediated cellular signaling. Given that GPCRs can influence various cellular functions, including the trafficking of proteins like MOSPD3, NF449 could indirectly inhibit the functional activity of MOSPD3 by modulating GPCR signaling.

Endothall

145-73-3sc-201325
sc-201325A
20 mg
100 mg
$49.00
$203.00
1
(1)

Endothall is an inhibitor that can disrupt ATPase activity. As MOSPD3 is a membrane protein, it may rely on ATP-driven processes for its proper function and localization. By inhibiting ATPases, Endothall can indirectly affect the activity of MOSPD3.